enkephalin, methionine has been researched along with Constipation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carney, JA; Go, L; Go, VL; Koch, TR | 1 |
Burks, TF; Gehrig, CA; Hruby, VJ; Lemcke, PK; Shook, JE | 1 |
2 other study(ies) available for enkephalin, methionine and Constipation
Article | Year |
---|---|
Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide.
Topics: Adult; Bombesin; Chronic Disease; Colon; Constipation; Enkephalin, Methionine; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Male; Middle Aged; Muscle, Smooth; Peptide PHI; Radioimmunoassay; Substance P; Vasoactive Intestinal Peptide | 1988 |
Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antidiarrheals; Constipation; Dose-Response Relationship, Drug; Endorphins; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Enkephalins; Gastrointestinal Motility; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Morphine; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1989 |